Danaher Corp (DHR)
250.80
+1.25
(+0.50%)
USD |
NYSE |
May 09, 14:58
Danaher SG&A Expense (Quarterly): 1.807B for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.807B |
December 31, 2023 | 766.00M |
September 30, 2023 | 2.145B |
June 30, 2023 | 2.194B |
March 31, 2023 | 1.772B |
December 31, 2022 | 798.00M |
September 30, 2022 | 2.149B |
June 30, 2022 | 2.085B |
March 31, 2022 | 2.092B |
December 31, 2021 | 903.00M |
September 30, 2021 | 2.062B |
June 30, 2021 | 1.966B |
March 31, 2021 | 1.876B |
December 31, 2020 | 1.957B |
September 30, 2020 | 1.796B |
June 30, 2020 | 1.685B |
March 31, 2020 | 1.458B |
December 31, 2019 | 1.449B |
September 30, 2019 | 1.382B |
June 30, 2019 | 1.39B |
March 31, 2019 | 1.368B |
December 31, 2018 | 592.60M |
September 30, 2018 | 1.559B |
June 30, 2018 | 1.638B |
March 31, 2018 | 1.602B |
Date | Value |
---|---|
December 31, 2017 | 572.00M |
September 30, 2017 | 1.498B |
June 30, 2017 | 1.522B |
March 31, 2017 | 1.450B |
December 31, 2016 | 1.519B |
September 30, 2016 | 1.346B |
June 30, 2016 | 1.431B |
March 31, 2016 | 1.328B |
December 31, 2015 | 1.370B |
September 30, 2015 | 1.201B |
June 30, 2015 | 1.405B |
March 31, 2015 | 1.414B |
December 31, 2014 | 141.00M |
September 30, 2014 | 1.298B |
June 30, 2014 | 1.394B |
March 31, 2014 | 1.351B |
December 31, 2013 | 1.176B |
September 30, 2013 | 1.303B |
June 30, 2013 | 1.340B |
March 31, 2013 | 1.298B |
December 31, 2012 | 1.406B |
September 30, 2012 | 1.251B |
June 30, 2012 | 1.279B |
March 31, 2012 | 1.245B |
December 31, 2011 | 1.288B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
766.00M
Minimum
Dec 2023
2.194B
Maximum
Jun 2023
1.687B
Average
1.802B
Median
SG&A Expense (Quarterly) Benchmarks
Quest Diagnostics Inc | 440.00M |
Natera Inc | 161.43M |
Delcath Systems Inc | 6.963M |
CytoSorbents Corp | 10.56M |
Progyny Inc | 43.09M |